Lung Cancer
From the Journals
Advanced imaging technology could help predict lung cancer progression after surgery
“AI can predict clinical outcomes when combined with [imaging mass cytometry] with extremely high accuracy from a single 1-mm2 tumor core.”
Opinion
Postop RT: Meaningful survival improvement in N2 lung cancer
“When you have patients with N2 disease, after the completion of systemic therapies, think about the use of PORT and get the advice of a radiation...
Feature
Could your patients benefit? New trials in lung cancer
Patients with untreated advanced non–small cell lung cancer (NSCLC) can join one of these randomized, open-label, phase 3 studies.
From the Journals
Less invasive NSCLC surgery does not compromise survival
New results contrast with those from a previous study from 1995.
Perspectives
Three wild technologies about to change health care
Now, in the 23rd year of the 21st century, you might not believe what we’ll be capable of next.
Conference Coverage
Gene test may offer insights into treatment response in advanced NSCLC
Researchers linked positive assay results to longer progression-free survival.
Feature
Cancer clinics begin to accommodate patients demanding new cancer detection tests
Sales teams are making a big push for multicancer early detection tests.
From the Journals
Over half of targetable NSCLC patients miss out on correct tx
For some patients it could mean missing the chance for long-term survival or even cure.
News
FDA rejects poziotinib for certain types of lung cancer
The clinical data the company submitted was deemed insufficient for approval.
Conference Coverage
Lung cancer screening pushes 20-year survival rate to 80%
Less than 6% of high-risk smokers get the recommended annual lung cancer screening.